Intrexon Raises $100M in Series E Round | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic biology firm Intrexon today announced the close of its Series E round of financing, which raised $100 million and brings the total capital raised by the company in its history to more than $259 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.